Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0371619950110010129
Journal of Wonkwang Medical Science
1995 Volume.11 No. 1 p.129 ~ p.136
Concurrent Cisplatin and Radiation Therapy for High Risk Group of Uterine Cervical Carcinoma



Abstract
Twelve patients with high risk group of uterine cervical carcinoma received concurrent chemoradiotherapy with weekly cisplatinum. A patient was FIGO stage I-B barrel-shaped, two were stage II-A, eight were stage II-B, and one was III-B, All
patients
responded to concurrent chemoradiotherapy with eleven complete and one partial responses. Nine of 11 with complete reponse are alive disease free on the completion of follow-up. Overall 3-year survival rate was 75% and 3-year local control rate
was
92%.
Toxicity for the combination therapy was not excessive. Although follow-up is short, this approach for patients with high risk uterine cervical carcinoma yielded excellent results and was well tolerated.
KEYWORD
FullTexts / Linksout information
Listed journal information